MDT Stock: Medtronic plc Stock Price, Analysis & Insights
Get live mdt stock price $90.40, comprehensive Medtronic plc stock analysis, charts, news, and expert forecast. Real-time mdt stock data and investment insights.
Loading chart...
Company Overview
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Company Information
- CEO
- Geoffrey Straub Martha
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 95000
Contact Information
- Website
- https://www.medtronic.com
- Address
- 20 On Hatch
- Country
- IE
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 116.0 billion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 25.0)
✓ Lower volatility stock (Beta: 0.74) may provide portfolio stability
Business Model & Strategy
Medtronic plc operates in the Medical - Devices industry, focusing on medical services, pharmaceutical development, and healthcare delivery. As a mid-cap company, Medtronic plc benefits from scale advantages, market presence, and established operations. Under the leadership of CEO Geoffrey Straub Martha, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Devices model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Medtronic plc competes in the Medical - Devices within the broader Healthcare. With 116.0 billion in market capitalization, the company is positioned as a established player in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, Medtronic plc provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Medtronic plc should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Medtronic plc shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Medtronic plc
- ⚠Investors should consider how Medtronic plc fits within their overall portfolio allocation
Market Cap
115.95B
P/E Ratio
24.97
Beta
0.74
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 115.95B market capitalization
- Trading Volume: 5.29M shares traded today
- Price Range: 52-week range of $79.29 - $99.37
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for Medtronic plc
Medtronic plc (MDT) operates in the Medical - Devices industry within the Healthcare sector. With a current market capitalization of 115.95B, the company represents a significant player in its market. The stock is currently trading at $90.40 with a negativedaily change of 0.02%.
The company's 95000 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 24.97, beta of 0.74, and 52-week price range from $79.29 to $99.37when evaluating investment opportunities.
Why Invest in Medtronic plc?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Geoffrey Straub Martha
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.